Stockreport

Waldencast: Strategic Reviews Are More Than Necessary [Seeking Alpha]

Waldencast Acquisition Corp. - Class A Ordinary Share  (WALD) 
PDF Obagi's medical-grade skincare and Novaestiq acquisition offer a more resilient, higher-margin TAM versus the challenged Milk Makeup segment. The $82.5M Obagi Japan r [Read more]